公司概覽
業務類別 Drug Manufacturers - Specialty & Generic
業務概覽 Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal productsused in cattle, sheep, goats, and swine production.
公司地址 450 ELANCO CIRCLE, INDIANAPOLIS, IN, USA, 46221
電話號碼 +1 877 352-6261
傳真號碼 --
公司網頁 https://www.elanco.com
員工數量 9400
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Ramiro Martin Cabral Executive Vice President and President of Elanco International 美元 620.00K 27/03/2025
Mr. David S. Kinard Executive Vice President, Human Resources, Corporate Communications and Administration -- 27/03/2025
Ms. Ellen de Brabander, PhD Executive Vice President, Innovation and Regulatory Affairs 美元 753.05K 27/03/2025
Mr. Rajeev A. Modi Executive Vice President, U.S. Pet Health and Global Digital Transformation -- 27/03/2025
Mr. Timothy J. Bettington Executive Vice President, Corporate Strategy and Market Development 美元 642.00K 27/03/2025
Ms. Grace McArdle Executive Vice President, Manufacturing and Quality -- 27/03/2025
Mr. James M. Meer Senior Vice President and Chief Accounting Officer -- 24/02/2026
Mr. Robert M. VanHimbergen Executive Vice President and Chief Financial Officer -- 24/02/2026
Ms. Shiv O'Neill Executive Vice President, General Counsel and Corporate Secretary -- 27/03/2025
Mr. Jose Manuel Correia de Simas, PhD Executive Vice President, U.S. Farm Animal Business -- 27/03/2025
Mr. Jeffrey N. Simmons President, Chief Executive Officer and Director 美元 1.20M 24/02/2026
 
董事會成員
董事會 職務 更新日期
Mr. Lawrence E. Kurzius Chairman of the Board 24/02/2026
Dr. Stacey Ma, PhD Independent Director 24/02/2026
Mr. Art A. Garcia Independent Director 24/02/2026
Mr. Kirk McDonald Independent Director 24/02/2026
Ms. Kapila Kapur Anand Independent Director 24/02/2026
Mr. Michael J. Harrington Independent Director 24/02/2026
Mr. R. David Hoover Independent Director 24/02/2026
Mr. Paul S. Herendeen Independent Director 24/02/2026
Dr. Deborah T. Kochevar, D.V.M.,PhD Independent Director 24/02/2026
Mr. Jeffrey N. Simmons President, Chief Executive Officer and Director 24/02/2026
Dr. Denise Vera Scots-Knight, PhD Independent Director 24/02/2026
 
所屬ETF (更新日期: 07/03/2026 03:49)
代號 名稱 佔比% 持有日期
MSLCMorgan Stanley Pathway Large Cap Eq ETF0.004%28/02/2026
TMEDT. Rowe Price Health Care ETF0.004%28/02/2026
GUSAGoldman Sachs MarketBeta US 1000 Eq ETF0.003%27/02/2026
PAMCPacer Lunt MidCap Multi-Factor Alt ETF0.003%03/02/2026
MVVProShares Ultra MidCap4000.003%27/02/2026
FNDBSchwab Fundamental U.S. Broad Market ETF0.003%28/02/2026
IUSInvesco RAFI™ Strategic US ETF0.003%27/02/2026
FTXHFirst Trust Nasdaq Pharmaceuticals ETF0.003%26/02/2026
AVLCAvantis U.S. Large Cap Equity ETF0.003%28/02/2026
PILLDirexion Daily Phrmctcl&MdclBl3XShrsETF0.002%26/02/2026
VFMFVanguard US Multifactor ETF0.002%31/12/2025
BCSMBaron SMID Cap ETF0.002%28/02/2026
JOYTJPMorgan Equity And Options Total Rt ETF0.002%27/02/2026
MIDUDirexion Daily Mid Cap Bull 3X ETF0.002%26/02/2026
PAWZProShares Pet Care ETF0.002%27/02/2026
DXUVDimensional US Vector Equity ETF0.002%27/02/2026
MKTNFederated Hermes MDT Market Neutral ETF0.002%28/02/2026
CVLCCalvert US Large-Cp Cor Rspnb ETF0.001%27/02/2026
GVUSGoldman Sachs MktBt Russell LgCpValEqETF0.001%27/02/2026
LSEQHarbor Long-Short Equity ETF0.001%28/02/2026
  1    2    3    4   5    6    7    8  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.